Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |